Abstract
Objective: To study the effect of a new fermented milk product containing GABA (FMG) on the blood pressure (BP) of patients with mild hypertension.
Design: A randomized, placebo-controlled, single-blind trial.
Setting: The study was carried out at the outpatient clinic of the Cardiovascular Disease Center, Tokyo Metropolitan Police Hospital, Japan.
Subjects: The study population comprised 39 mildly hypertensive patients (16 women and 23 men) aged 28–81 y (mean, 54.2 y).
Interventions: The study consisted of a 12-week period of daily intake of FMG or placebo (weeks 1–12) followed by 2 weeks of no intake (weeks 13 and 14). We measured the peripheral BP and heart rate of seated patients at weeks 0, 2, 4, 8, 12 and 14. Routine blood study and urinalysis were performed before and after the intake.
Results: There was a significant decrease of BP within 2 or 4 weeks, and it remained decreased throughout the 12-week intake period. For the FMG recipients, the mean decrease after 12 weeks was 17.4±4.3 mmHg in the systolic BP (SBP) and 7.2±5.7 mmHg in the diastolic BP (DBP). Both of these values differed statistically from baseline levels (P<0.01), and the SBP of the FMG group differed from the placebo group (P<0.05). Heart rate, body weight, hematological and blood chemistry variables, and urinalysis results (glucosuria and proteinuria) did not vary both groups throughout the study.
Conclusions: FMG may contribute to lowering BP in mildly hypertensive people.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Billingsley, M & Suria, A (1982). Effects of peripherally administered GABA and other amino acids on cardiopulmonary responses in anesthetized rats and dogs. Arch. Int. Pharmacodyn., 255, 131–140.
Elliott, KAC & Hobbiger, F (1959). Gamma aminobutyric acid: circulatory and respiratory effects in different species: re-investigation of the anti-strychnine action in mice. J. Physiol., 146, 70–84.
Erdö, SL & Wolff, JR (1990). γ-Aminobutyric acid outside the mammalian brain. J. Neurochem., 54, 363–372.
Giuliani, S, Maggi, AC & Meli, A (1986). Differences in cardiovascular responses to peripherally administered GABA as influenced by basal conditions and type of anaesthesia. Br. J Pharmac., 88, 659–670.
Guidelines Subcommittee of WHO/ISH (1999). 1999 World Health Organization—International Society of Hypertension guide-lines for the management of hypertension. J. Hypertens., 17, 165–166.
Hayakawa, K, Kimura, M & Kamata, K (2002). Mechanism underlying gamma-aminobutyric acid-induced antihypertensive effect in spontaneously hypertensive rats. Eur. J. Pharmac., 438, 107–113.
Jorde, R & Bønaa, KH (2000). Calcium from dairy products, vitamin D intake, and blood pressure: the Tromsø study. Am. J. Clin. Nutr., 71, 1530–1535.
Kawano, Y, Matsuoka, H, Takishita, S & Omae, T (1998). Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension, 32, 260–265.
Kawase, M, Hashimoto, H, Hosoda, M, Morita, H & Hosono, A (2000). Effect of administration of fermented milk containing whey protein concentrate to rats and healthy men on serum lipids. J. Dairy Sci., 83, 255–263.
Kuriyama, K & Sze, Y (1971). Blood–brain barrier to H3-γ-aminobutyric acid in normal and amino oxyacetic acid-treated animals. Neuropharmacology, 10, 103–108.
Miller, GD, DiRienzo, DD, Reusser, ME & MacCarron, DA (2000). Benefits of dairy product consumption on blood pressure in humans: a summary of the biomedical literature. J. Am. Coll. Nutr., 19, 147S–164S.
Ministry of Health, Labor, Welfare in Japan (1989). Guideline for the Clinical Evaluation of Antihypertensive Drugs, p488(in Japanese)
Nakamura, Y, Yamamoto, N, Sakai, K, Okubo, A, Yamazaki, S & Takano, T (1995). Purification and characterization of angiotensin I-converting enzyme inhibitor from sour milk. J. Dairy Sci., 78, 777–783.
Nicol, RA, Malenka, RC & Kauer, JA (1990). Functional comparison of neurotransmitter receptor subtypes in mammalian central nervous system. Physiol. Rev., 70, 513–565.
Onoda, A, Saikusa, T, Horino, T, Kajimoto, A, Miyamoto, A, Tanaka, Y, Murakami, T, Okada, & Murai, H (1998). Accumulative effects of γ-aminobutyric acid (GABA) from defatted rice germ. The First International Symposium on Disease Prevention by IP6 and Other Rice Components, p97
Oomori, S, Yano, T, Okamoto, J, Tushida, F, Murai, T & Higuchi, M (1987). Effect of anaerobically treated tea (Gabaron tea) on the blood pressure of spontaneously hypertensive rats. Nippon Nôgeikagaku Kaishi, 61, 1449–1451, (abstract in English)
Pawlowska, M, Chen, S & Armstrong, D (1993). Enantiomeric separation of fluorescent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate-tagged amino acids. J. Chromatogr., 641, 257–265.
Research Group of γ-Aminobutyric Acid in Tokyo (1960). Clinical aspects on the use of gamma-aminobutyric acid. In:Inhibition in the Nervous System and Gamma-aminobutyric Acid. Proceedings of an International Symposium, City of Hope Medical Center, Duarte, California, 22–24 May, 1959, pp579–581, Oxford: Pergamon Press
Stanton, HC (1963). Mode of action of gamma aminobutyric acid on the cardiovascular system. Arch. Int. Pharmacodyn., 143, 195–204.
Takahashi, H, Tiba, M, Iino, M & Takayasu, T (1955). The effect of γ-aminobutyric acid on blood pressure. Jpn. J. Physiol., 5, 334–341.
Tanaka, C (1985). γ-Aminobutyric acid in peripheral tissues. Life Sci., 37, 2221–2235.
Tsuji, K, Ichikawa, T, Tanabe, N, Abe, S, Tarui, S & Nakagawa, Y (1992). Antihypertensive activities of Beni-Koji extracts and γ-aminobutyric acid in spontaneously hypertensive rats. Jpn. J. Nutr., 50, 285–291, (abstract in English)
Van Gelder, MN & Elliott, KAC (1958). Disposition of γ-aminobutyric acid administered to mammals. J. Neurochem., 3, 139–143.
Yamamoto, N, Maeno, M & Takano, T (1999). Purification and characterization of an antihypertensive peptide from a yogurt-like product fermented by Lactobacillus helveticus CPN4. J. Dairy Sci., 82, 1388–1393.
Acknowledgements
We thank Mr Y Suzuki and his coworkers (Development Division, Yakult Honsha Co. Ltd, Japan) for preparing the fermented milk and placebo products.
Author information
Authors and Affiliations
Contributions
Guarantor: K Inoue.
Contributors: KI managed and organized the study. KI and TS participated in the conception and design of the study and in writing the article with KH and MKi. KI, TS, HO, and MKa recruited the subjects and collected the data. KH, MKi, and HS developed and distributed the test products.
Corresponding author
Rights and permissions
About this article
Cite this article
Inoue, K., Shirai, T., Ochiai, H. et al. Blood-pressure-lowering effect of a novel fermented milk containing γ-aminobutyric acid (GABA) in mild hypertensives. Eur J Clin Nutr 57, 490–495 (2003). https://doi.org/10.1038/sj.ejcn.1601555
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ejcn.1601555
Keywords
This article is cited by
-
Creation and gene expression analysis of a giant embryo rice mutant with high GABA content
Molecular Breeding (2023)
-
Mapping of quantitative trait loci for the nutritional value of fresh market tomato
Functional & Integrative Genomics (2023)
-
Comparative Chemical Characterization of Potato Powders Using 1H NMR Spectroscopy and Chemometrics
Plant Foods for Human Nutrition (2023)
-
The genomic basis of the Streptococcus thermophilus health-promoting properties
BMC Genomics (2022)
-
Improve gamma-aminobutyric acid production in Corynebacterium glutamicum by optimizing the metabolic flux
Systems Microbiology and Biomanufacturing (2022)